Defensin Peptides in Belly Fluid Can Rapidly Diagnose a Life-Threatening Abdominal Infection | Research

The takeaway

MALDI mass spectrometry detected human defensin peptides (HNP-1, HNP-2) in ascitic fluid as biomarkers for spontaneous bacterial peritonitis, achieving 0.956 AUC diagnostic accuracy in minutes instead of the 24-48 hours needed for culture.

AUC 0.956 in minutes
Combining defensin HNP-2 with a fibrinogen peptide fragment diagnosed spontaneous bacterial peritonitis with 95.6% accuracy — results available in minutes vs. 1-2 days for culture

What the researchers found

MALDI-TOF mass spectrometry combined with PLS-DA statistical analysis could rapidly distinguish spontaneous bacterial peritonitis (SBP) from noninfected ascites by analyzing protein and lipid fingerprints directly from ascitic fluid — without the need for bacterial culture. Alpha-defensins, particularly human neutrophil peptides HNP-1 and HNP-2, emerged as promising SBP biomarkers. A novel fibrinogen fragment peptide (SSSYSKQFTSSTSYNRGDSTFES) was associated with non-infected ascites. Combining HNP-2 with this fibrinogen peptide achieved an AUC of 0.956 for SBP diagnosis — far superior to current clinical indicators.

Why it matters

Spontaneous bacterial peritonitis is a life-threatening infection in patients with liver cirrhosis and ascites. Current diagnosis relies on culture-based methods that take 24-48 hours, during which patients can deteriorate rapidly. This MALDI-TOF approach delivers results in minutes to hours, enabling much faster antibiotic treatment. The identification of defensin peptides as biomarkers connects innate immunity (the body's first-line defense peptides) to rapid diagnostics.

The numbers in context

AUC 0.956 (HNP-2 + fibrinogen peptide) · Results: minutes to hours vs. 24-48h culture · Lipids: 500-1000 Da · Proteins: 2,000-20,000 Da · α-defensins (HNP-1, HNP-2) = SBP biomarkers · No bacterial culture needed

How the study worked

Ascitic fluid from patients with SBP and non-infected ascites was analyzed directly by MALDI-TOF mass spectrometry, measuring both lipid species (500-1000 Da) and intact proteins (2,000-20,000 Da). Partial least squares discriminant analysis (PLS-DA) was used to classify samples and identify discriminating features. Specific peptide biomarkers were identified and combined for diagnostic accuracy assessment (AUC analysis).

What this study cannot tell us

Sample sizes are not specified in the abstract. The AUC of 0.956 is impressive but needs validation in larger, independent cohorts. MALDI-TOF mass spectrometry requires specialized equipment not available in all hospitals. The study focused on distinguishing SBP from non-infected ascites but didn't address identification of the specific bacterial species causing infection.

How to read the evidence

This is a diagnostic accuracy study using advanced mass spectrometry and statistical classification. The AUC of 0.956 is excellent, but sample sizes aren't reported in the abstract and external validation in independent cohorts is needed before clinical adoption.

When this study was published

Published in 2025, this is a very recent study applying state-of-the-art diagnostic technology to a common clinical problem. MALDI-TOF mass spectrometry is already available in many hospital microbiology labs, which could facilitate adoption.

The bigger picture

This study elegantly connects two peptide biology fields: innate immunity (defensins as the body's natural antibiotics) and clinical diagnostics (using those same peptides as disease biomarkers). Human neutrophil peptides are released when neutrophils encounter bacteria, making them a direct readout of immune activation at the infection site. The diagnostic approach is part of a broader trend toward culture-independent, rapid diagnostics using mass spectrometry — a technology already common in microbiology labs for bacterial identification.

Questions still open

Can this MALDI-TOF defensin assay be standardized and validated across multiple hospitals for routine clinical use?
Would defensin levels in ascitic fluid also predict SBP severity or treatment response?
Could this approach be extended to detect other types of body fluid infections (pleural, joint) using the same defensin biomarkers?

Common questions

What are defensins and why do they appear in infected fluid?

Defensins (specifically HNP-1 and HNP-2) are antimicrobial peptides stored inside neutrophils — white blood cells that are the first responders to bacterial infection. When neutrophils encounter bacteria in the abdominal fluid, they release defensins to kill the invaders. Elevated defensin levels in the fluid are a direct signal that infection is occurring — making them excellent biomarkers.

Why is faster diagnosis of SBP so important?

Spontaneous bacterial peritonitis kills about 20-30% of hospitalized cirrhosis patients who develop it. Survival depends on starting antibiotics quickly, but the current test (bacterial culture) takes 24-48 hours. During that delay, patients can deteriorate rapidly. A test that gives results in minutes instead of days could significantly improve survival by enabling immediate, appropriate antibiotic treatment.

Read the original research

Multiplexed MALDI fingerprints for rapid detection of spontaneous bacterial peritonitis.

Diagnostic microbiology and infectious disease, 113(3), 116980

View on PubMed ↗Publisher’s paper ↗

Citation

Wu, Qiong; Wei, Bo; Zhang, Han; Shen, Jiayi; Yang, Xinyan; Qiu, Chengtong; Tao, Jian; Wang, Shijie; Wang, Junxue; Xie, Ying; Du, Yiping; Wu, Ting. (2025). Multiplexed MALDI fingerprints for rapid detection of spontaneous bacterial peritonitis.. Diagnostic microbiology and infectious disease, 113(3), 116980. https://doi.org/10.1016/j.diagmicrobio.2025.116980